Presentations
Filter by:
Search
Year
November 10, 2020
Eyecelerator 2020 Presentation
Trefoil provided an update on the company and its clinical program for TTHX1114 at the inaugural Eyecelerator 2020 virtual conference on November 6. TTHX1114 is the company’s first-in-class, engineered fibroblast growth factor 1 (FGF-1), for the regenerative treatment of corneal diseases.
Read MoreMay 7, 2020
ARVO 2020: Accelerated Healing of Corneal Lesions
Trefoil Therapeutics presents accelerated healing of corneal endothelial lesions by engineered fibroblast growth factor at ARVO 2020.
Read More